MENU
HELX
ETF ticker: BATS
PRICE
CHANGE
NET ASSETS

Franklin Genomic Advancements ETF (HELX) Ownership - Who owns Franklin Genomic Advancements ETF?

Category: @Health

Profile

Category
Health
Address
Franklin Templeton ETF TrustONE FRANKLIN PARKWAYSAN MATEO
Phone
N/A
Web
etf.franklintempleton.com

Details

Group
Domestic Stock Funds
Category
Health
Net Assets
9616633.00
Fund Existence
over 4 years
Turnover
32.63
Capitalization
N/A
Yield
N/A
Total Expense Ratio
N/A
Investment Style
N/A
Risk (Beta)
N/A

Fundamentals

HELX
Net Assets
9.62M
Yield
0.00
Fund Existence
over 4 years
Total Expense Ratio
N/A
Turnover
32.63
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
N/A
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
N/A
Assets in Top Ten Holdings
4.12M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
9.62M
Fund Type
ETF
Index Fund
No
Management Fee
N/A
Modified Duration
N/A
No Load Fund
No
Number of Long Holdings
66.00
Number of Net Holdings
N/A
Number of Short Holdings
N/A
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
N/A
Gain YTD
5.099
View a ticker or compare two or three
HELX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Franklin Templeton ETF TrustONE FRANKLIN PARKWAYSAN MATEO
Phone
N/A
Web
etf.franklintempleton.com